Evidence map›Paper›PMID 37024866›Full record

ArticleBMC cancer2023

Identification of hub genes and pathways in lung metastatic colorectal cancer.

Wei Dai, Caiyao Guo, Yu Wang, Yumei Li, Renjian Xie, Junhong Wu, Baole Yao, Dong Xie, Ling He, Yingying Li and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Exploring the potential function of high expression ofWorld journal of gastrointestinal oncology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Wei Dai *School of Pharmacy, Gannan Medical University, Ganzhou, 341000, China.
Caiyao Guo *School of Rehabilitation Medicine, Gannan Medical University, Ganzhou, 341000, China.
Yu Wang *School of Rehabilitation Medicine, Gannan Medical University, Ganzhou, 341000, China.
Yumei LiKey Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, Gannan Medical University, Ganzhou, 341000, China.
Renjian XieKey Laboratory of Biomaterials and Biofabrication in Tissue Engineering of Jiangxi Province, Gannan Medical University, Ganzhou, 341000, China.
Junhong WuSchool of Pharmacy, Gannan Medical University, Ganzhou, 341000, China.
Baole YaoSchool of Rehabilitation Medicine, Gannan Medical University, Ganzhou, 341000, China.
Dong XieSchool of Rehabilitation Medicine, Gannan Medical University, Ganzhou, 341000, China.
Ling HeSchool of Rehabilitation Medicine, Gannan Medical University, Ganzhou, 341000, China.
Yingying LiSchool of Pharmacy, Gannan Medical University, Ganzhou, 341000, China.
Hao HuangSchool of Pharmacy, Gannan Medical University, Ganzhou, 341000, China.
Yun WangScientific Research Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, China. wangy877@mail.sysu.edu.cn.
Shenglan LiuSchool of Pharmacy, Gannan Medical University, Ganzhou, 341000, China. liushl5@gmu.edu.cn.
Gannan Medical University · CNThe Seventh Affiliated Hospital of Sun Yat-sen University · CN

Funding

National Natural Science Foundation of China 82003797National Natural Science Foundation of China 82003801National Natural Science Foundation of China 82111530101Natural Science Foundation of Jiangxi Province 20224BAB216121
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is one of the most prevalent types of malignant tumours. Metastasis is the leading cause of cancer-related mortality, with lung metastases accounting for 32.9% of all metastatic CRCs. However, since the biological mechanism of lung metastatic CRC is poorly understood, limited therapeutic targets are available. In the present study, we aimed to identify the key genes and molecular processes involved in CRC lung metastasis.

methodsThe differentially expressed genes (DEGs) between primary and lung metastatic CRC patients were obtained from the Gene Expression Omnibus (GEO) database via the GEO2R tool. The enriched biological processes and pathways modulated by the DEGs were determined with Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Reactome Gene Sets analyses. The search tool Retrieval of Interacting Genes (STRING) and Cytoscape were used to construct a protein-protein interaction (PPI) network among DEGs.

resultsThe DEGs were enriched in surfactant metabolism, cell-cell communication and chemokine signaling pathways. The defined hub genes were included CLU, SFTPD, CCL18, SPP1, APOE, BGN and MMP3. Among them, CLU, SFTPD and CCL18 might be associated with the specific lung tropism metastasis in CRC. In addition, the expression and prognostic values of the hub genes in CRC patients were verified in database of The Cancer Genome Atlas (TCGA) and GEO. Moreover, the protein levels of the hub genes were detected in primary and lung metastatic CRC cells, serum or tissues. Furthermore, SFTPD was confirmed to facilitate cellular proliferation and lung metastasis in CRC.

conclusionThis bioinformatics study may provide a better understanding of the candidate therapeutic targets and molecular mechanisms for CRC lung metastasis.

Indexed as

Colonic NeoplasmsColorectal NeoplasmsLung NeoplasmsRectal NeoplasmsComputational BiologyGene Expression ProfilingGene Expression Regulation, NeoplasticHumansLungProtein Interaction MapsBioinformatics analysisColorectal cancerDifferentially expressed genesHub geneSFTPD

Identifiers

PMID37024866
PMCPMC10080892
OpenAlexW4362677694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.